Caditam
✅ Reduces breast cancer risk
✅ Treats breast cancer
✅ Lowers tumor recurrence
✅ Prevents osteoporosis
✅ Regulates estrogen levels
Caditam contains Tamoxifen.
✓ Медицински преглед от Morgan Ellis — Фармацевтичен изследовател · 8 години опит · Последен преглед: май 2026 г.
💡 Бърз отговор
Caditam е tamoxifen , a selective estrogen receptor modulator (SERM) and the first-line endocrine therapy for estrogen receptor-positive (ER+) breast cancer — used for adjuvant treatment (post-surgery/radiation), metastatic disease, and risk reduction in women at high genetic risk. Daily oral therapy, typically for 5–10 years. Anti-estrogenic in breast tissue but pro-estrogenic in bone and uterus — hence the endometrial cancer and VTE risk signals.
📦 Всяка поръчка е покрита от нашата Политика за повторна изпратка — ако вашата пратка не пристигне в рамките на 20 работни дни, ние я изпращаме отново.
Защо да поръчвате от MedsBase
Нашите генерични лекарства се доставят от производители, сертифицирани от WHO-GMP, и се изпращат по целия свят в дискретна, обикновена опаковка — без име на лекарството външно на пратката. Плащанията с карта се обработват чрез регулиран процесор (описанието на извлечението включва регулиран процесор за плащане с карта — никога “MedsBase” или име на лекарство). Приемат се също криптовалути и банков превод SEPA. Всяка поръчка е подкрепена от нашата политика за гарантирано преизпращане.
What Is Caditam?
Caditam is a branded generic of tamoxifen, a selective estrogen receptor modulator. Tamoxifen competitively blocks estrogen binding in breast tissue (anti-estrogenic effect — cancer-inhibitory) but acts as a partial agonist in bone, uterus, and cardiovascular tissue. Available at .
Клинични приложения
- Adjuvant therapy for ER+ early breast cancer — 5 years minimum, often extended to 10 years based on ATLAS and aTTom trial data (further 4–5% absolute reduction in breast cancer deaths with extended duration).
- Metastatic (advanced) breast cancer — hormonally responsive disease.
- Ductal carcinoma in situ (DCIS) — post-lumpectomy to reduce local recurrence.
- Breast cancer risk reduction in high-risk women (family history, BRCA1/2 mutation, LCIS, high Gail score).
- Premenopausal women: tamoxifen is first-line; aromatase inhibitors only work post-menopause.
- Anovulatory infertility (off-label) — 20–40 mg on days 3–7 of cycle.
- Gynaecomastia treatment and prevention (off-label in men).
Как се приема
- Приемете 20 mg once daily (standard adjuvant dose). Some metastatic protocols use higher doses. With or without food, at the same time each day.
- Standard duration: 5 years. Extended to 10 years in many clinical situations based on ATLAS/aTTom.
- Do not stop abruptly — talk to your oncologist if adverse effects are difficult.
- Contraception required. Tamoxifen is teratogenic — use effective non-hormonal contraception during treatment and 2 months after.
- Annual gynaecological check recommended — post-menopausal users have 2–3× endometrial cancer risk; any abnormal vaginal bleeding must be investigated promptly.
Странични ефекти
Чести: hot flushes, night sweats, menstrual irregularity, vaginal discharge or dryness, mood changes, decreased libido, fatigue, nausea.
По-рядко: weight changes, fluid retention, rash, muscle cramps.
Serious (rare but important): endometrial cancer (2–3× risk in postmenopausal women; investigate any abnormal vaginal bleeding), VTE (DVT/PE — 2–3× risk), stroke (modest increase), cataracts, hepatotoxicity (rare), uterine sarcoma (very rare).
Who Should Not Take Caditam
- Pregnancy or planned pregnancy (teratogenic) — use non-hormonal contraception
- Active VTE (DVT or PE), thrombophilia, or recent stroke
- Concurrent strong CYP2D6 inhibitors (paroxetine, fluoxetine) — reduce tamoxifen activation
- Undiagnosed abnormal vaginal bleeding
- Active liver disease
Key Drug Interactions
- SSRI antidepressants (paroxetine, fluoxetine): strong CYP2D6 inhibitors that reduce tamoxifen’s conversion to its active metabolite endoxifen — prefer venlafaxine, duloxetine, or citalopram for concurrent depression treatment.
- Warfarin: tamoxifen potentiates warfarin effect — monitor INR carefully.
- Aromatase inhibitors (anastrozole, letrozole): not combined — different drug classes for different menopausal status.
- Rifampicin, carbamazepine: may reduce tamoxifen levels via CYP3A4 induction.
Tamoxifen vs Aromatase Inhibitors
Premenopausal: tamoxifen is first-line (AIs don’t work when ovaries are active). Postmenopausal: aromatase inhibitors (letrozole, anastrozole, exemestane) are preferred — slightly better disease-free survival, different side-effect profile (joint pain, bone loss rather than hot flushes and endometrial cancer). Many postmenopausal regimens sequence tamoxifen then AI or vice versa. See Letroheal (Letrozole).
Съхранение
Store at room temperature (15–25 °C). Keep in original blister. Keep out of reach of children.
Често задавани въпроси
How long do I take tamoxifen?
Standard is 5 years. Extending to 10 years reduces breast cancer recurrence and mortality further (ATLAS/aTTom trials). Your oncologist will individualise.
Will tamoxifen cause menopause?
Tamoxifen can cause menopausal-like symptoms (hot flushes, vaginal dryness) but does not medically induce menopause. Premenopausal women on tamoxifen usually continue to have periods, though irregularly.
Does tamoxifen cause weight gain?
A small average weight gain (2–3 kg) is reported in trials, often from reduced activity during cancer recovery rather than a direct drug effect.
Why do I need to watch for bleeding?
Tamoxifen stimulates the endometrium and raises endometrial cancer risk 2–3× in postmenopausal women. Any postmenopausal vaginal bleeding or any heavy/prolonged premenopausal bleeding requires urgent gynaecological assessment.
Can I combine tamoxifen with an SSRI?
Avoid paroxetine and fluoxetine — they reduce tamoxifen’s anti-cancer metabolite. Venlafaxine, duloxetine, and citalopram are preferred for antidepressant co-therapy.
What if I get joint pain?
Tamoxifen joint pain is less common than aromatase inhibitor joint pain but occurs. Maintain activity, consider paracetamol/NSAIDs short-term, and report to your oncologist if severe.
Does tamoxifen protect bones?
Yes — in postmenopausal women, tamoxifen is slightly bone-protective (partial estrogen agonist in bone). Aromatase inhibitors have the opposite effect.
Will my cancer come back if I stop early?
Stopping before 5 years raises recurrence risk. Discuss with your oncologist — side-effect management, dose reduction, or switching to an AI may be preferable to stopping.
Related Women’s Health Products
- Tamodex (Tamoxifen 10 mg)
- Tamilong (Tamoxifen 20 mg)
- Letroheal (Letrozole 2.5 mg)
- Etibo (Lapatinib 250 mg)
- Duphaston (Dydrogesterone 10 mg)
- Deviry (Medroxyprogesterone 10 mg)
- Naprosyn (Naproxen 250 mg)
⚕️ Медицинско предупреждение: Information is educational and does not replace medical advice. Consult a clinician before starting, stopping, or changing any medication, particularly for cancer therapy, hormonal treatments, and prescription products.
Свързани алтернативи
Other oncology medications stocked alongside this product:
More options in Anti Cancer Medication
Класирани според скорошния обем на поръчки в MedsBase — какво избират други клиенти в тази категория.
| Сила | 20 mg |
|---|---|
| Количество | 30 Таблетки, 60 Таблетки, 90 Таблетки, 180 Таблетки |
Caditam
Въпроси и отговори
Caditam
Свързани продукти
Отзиви
Все още няма отзиви